- Companies
- ThirdWaveRx
ThirdWaveRx Funding, Investors & Competitors
ThirdWaveRx has raised $140M across 2 funding rounds, most recently a $20M undisclosed-stage round in October 2022.
Last ThirdWaveRx funding round
$20M
Undisclosed stage · Oct 2022
Cumulative funding ThirdWaveRx raised
$140M
across 2 funding rounds
Key investors in ThirdWaveRx
WindRose Health Investors
About ThirdWaveRx
ThirdWaveRx is a pharmaceutical rebate management company handling PBM relationships and eligibility reviews. Founded in 2021 and headquartered in Las Vegas, Nevada, ThirdWaveRx helps healthcare organizations optimize their pharmaceutical spending through rebate optimization.
Founded
2021
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
ThirdWaveRx Funding History
ThirdWaveRx has raised a total of $140M across 2 funding rounds.
ThirdWaveRx's first fundraising round was a $120M undisclosed-stage round in September 2022. The most recent completed round was a $20M undisclosed-stage round in October 2022.
ThirdWaveRx funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Oct 2022 | Undisclosed stage | - | $20M | - |
| Sep 2022 | Undisclosed stage | WindRose Health Investors (lead) | $120M | Third Wave Recovery Systems (TWRx), based in Las Vegas, is a provider of rebate administration services for hospitals, long-term care (LTC) facilities, and select specialty physician groups. On September 16, 2022, WindRose Health Investors, a New York-based healthcare private equity firm, completed an investment in TWRx, pursuing control equity in healthcare services including outsourced services to payors and health systems. In conjunction with WindRose's investment, TWRx acquired SRX, LLC, a New York-based leader in pharmaceutical rebate management for the skilled nursing and LTC industry. The combined entity appointed a new executive team led by CEO Ed Lagerstrom, formerly President of UnitedHealthcare Networks, with co-founder Eric Moskow, M.D., transitioning to Chairman and remaining a significant shareholder. WindRose Partner Alex Buzik highlighted the acquisition as cementing TWRx as the premier platform in rebate and prescription drug management. WindRose's investment aims to support TWRx's strong momentum and rapid growth in the rebate administration marketplace through industry knowledge and relationships. The firm, founded in 2000, targets technology-enabled services and healthcare providers. |
Who has invested in ThirdWaveRx?
1 investor has backed ThirdWaveRx across its funding rounds, including WindRose Health Investors.
Lead investors include WindRose Health Investors.
ThirdWaveRx Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 ThirdWaveRx investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by ThirdWaveRx
ThirdWaveRx has acquired 1 company to date.
Last acquisition by ThirdWaveRx was on September 14th 2022. ThirdWaveRx acquired SRX for undisclosed valuation.
Latest Acquisitions by ThirdWaveRx
| Description | SRX is a software platform for long-term care and skilled nursing facilities that automates rebate eligibility, formulary checks, and compliance with pharmacy integrations. The technology connects electronic health records, drug databases, and facility protocols to streamline medication management. SRX serves U.S. healthcare providers by reducing administrative burdens in rebate processing and regulatory reporting. |
| HQ Country | |
| HQ City | New York City, NY |
| Deal Date | 14 Sep 2022 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all ThirdWaveRx acquisitions and their M&A valuation multiples. Start Free Trial | |
ThirdWaveRx Competitors
ThirdWaveRx competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x | ||
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $7.9B | $3.2B | $37B | 5.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $400M | - | $6.4B | 16.0x |
ThirdWaveRx Public Comps
ThirdWaveRx is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging, Glaukos and M3 Inc..
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $8.3B | $816M | 1.9x | 1.9x | 19.2x | 11.3x | |||
| $186M | $147M | 66.6x | 62.7x | 84.4x | 77.6x | |||
| $2.1B | $367M | 5.5x | 4.8x | 30.7x | 26.9x | |||
This data is available for Pro users. Sign up to see all ThirdWaveRx competitors and their valuation data. Start Free Trial | ||||||||
Common questions about ThirdWaveRx
| When was ThirdWaveRx founded? | ThirdWaveRx was founded in 2021. |
| Where is ThirdWaveRx headquartered? | ThirdWaveRx is headquartered in Las Vegas, NV, United States. |
| Is ThirdWaveRx publicly listed? | No, ThirdWaveRx is a private, VC-backed company. |
| How much funding has ThirdWaveRx raised? | ThirdWaveRx has raised $140M across 2 funding rounds. |
| What was ThirdWaveRx's last funding round? | ThirdWaveRx's last funding round was a $20M undisclosed-stage round in October 2022. |
| Who are ThirdWaveRx's investors? | ThirdWaveRx's investors include WindRose Health Investors. |
| Which companies are comparable to ThirdWaveRx? | Companies comparable to ThirdWaveRx include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib. |
| How many companies has ThirdWaveRx acquired? | ThirdWaveRx has acquired 1 company, including SRX. |
See companies similar to ThirdWaveRx
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




